SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-15-000703
Filing Date
2015-02-26
Accepted
2015-02-26 16:29:04
Documents
4
Period of Report
2015-02-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ohr-8k_022415.htm 8-K 25939
2 EMPLOYMENT AGREEMENT ex10-52.htm EX-10 74318
3 PRESS RELEASE ex99-1.htm EX-99 10257
4 GRAPHIC logo.jpg GRAPHIC 5027
  Complete submission text file 0001387131-15-000703.txt   119024
Mailing Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022
Business Address 800 THIRD AVENUE 11TH FLOOR NEW YORK NY 10022 (212) 682-8452
Ohr Pharmaceutical Inc (Filer) CIK: 0001173281 (see all company filings)

IRS No.: 465622433 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35963 | Film No.: 15652943
SIC: 2834 Pharmaceutical Preparations